Treatment with Intranasal Insulin May Improve Verbal Fluency and Motor Function, Early Study Shows

Treatment with Intranasal Insulin May Improve Verbal Fluency and Motor Function, Early Study Shows
Treatment with intranasal insulin — which is atomized into a spray and inhaled through the nose — may ease Parkinson’s disease-related cognitive impairment and motor symptoms without dangerously lowering blood sugar levels, according to a proof-of-concept trial. The study, “Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study,” ... read more
Source: Parkinson’s News TodayPublished on 2019-05-02By Catarina Silva